The continuing challenge of anti-neutrophil cytoplasm antibody-associated systemic vasculitis and glomerulonephritis

Journal of the American Society of Nephrology

Volumn 17, Issue 5, 2006, Pages 1221-1223

  Pusey, Charles D ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

EVIDENCE BASED MEDICINE; EXPERIENCE; GLOMERULONEPHRITIS; GOODPASTURE SYNDROME; HUMAN; LABORATORY DIAGNOSIS; PLASMAPHERESIS; POLYARTERITIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 33646354903     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006030192     Document Type: Review

References (24)

1. Pinching AJ, Lockwood CM, Pussell BA, Rees AJ, Sweny P, Evans DJ, Bowley N, Peters DK: Wegener's granulomatosis: Observations on 18 patients with severe renal disease. Q J Med 52: 435-460, 1983
2. Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM: Microscopic polyarteritis: Presentation, pathology and prognosis. Q J Med 56: 467-483, 1985
3. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM: Plasma exchange in focal necrotising glomerulonephritis without anti-GBM antibodies. Kidney Int 40: 757-763, 1991
4. van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH: Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 23: 425-429, 1985
5. Davies DJ, Moran JE, Niall JF, Ryan GB: Segmental necrotising glomerulonephritis with antineutrophil antibody: Possible arbovirus aetiology? BMJ 28: 606, 1982
6. Ludemann J, Utecht B, Gross WL: Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 171: 357-362, 1990
7. Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318: 1651-1657, 1988
8. Watts R, Lane S, Bentham G, Scott D: Epidemiology of systemic vasculitis. A ten year study in the United Kingdom. Arthritis Rheum 43: 414-419, 2000
9. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187-192, 1994
10. Falk RJ, Terrell RS, Charles LA, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 87: 4115-4119, 1990
11. Ben-Smith A, Dove SK, Martin A, Wakelam MJ, Savage CO: Antineutrophil cytoplasmic autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signalling cascades: Comparison with conventional Fc gamma receptor ligation. Blood 98: 1448-1455, 2001
12. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110: 955-963, 2002
13. Little MA, Smyth CL, Yadav R, Ambrose L, Cook T, Nourshargh S, Pusey CD: Anti-neutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 106: 2050-2058, 2005
14. Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CG: T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immunol 98: 448-453, 1994
15. Griffith ME, Coulthart A, Pusey CD: T cell responses to myeloperoxidase and proteinase 3 in patients with systemic vasculitis. Clin Exp Immunol 103: 253-258, 1996
16. Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener's granulomatosis prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98: 76-85, 1983
17. Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, Plaisance M, Pusey CD, Jayne DR; for the Pan-Thames Renal Research Group: Outcome of ANCA-associated renal vasculitis: A 5-year retrospective study. Am J Kidney Dis 41: 776-784, 2003
18. Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH: Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143: 621-631, 2005
19. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS: Wegener's granulomatosis: An analysis of 158 patients. Ann Intern Med 116: 488-498, 1992
20. De'Oliviera J, Gaskin G, Dash A, Rees AJ, Pusey CD: Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis. Am J Kidney Dis 25: 380-389, 1995
21. Han WK, Choi HK, Roth RM, McCluskey RT, Niles JL: Serial ANCA titers: Useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int 63: 1079-1085, 2003
22. Jayne D, Rasmussen N, Andrassy K, Bacon P, Cohen Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey CD: A randomised trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349: 36-44, 2003
23. de Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DR: Randomised trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52: 2461-2469, 2005
24. Wegener's Granulomatosis Etanercept Trial (WGET) Research Group: Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 352: 330-332, 2005